Burden of Tracheal, Bronchus, and Lung Cancer Attributable to High Fasting Plasma Glucose
Archives of Iranian Medicine · 2025
DOI: 10.34172/aim.33332 ↗Kurz gefasst
Fachartikel in der Zeitschrift Archives of Iranian Medicine, 2025. Verfasst von Jingyi Zhou und 4 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, Ninghai Traditional Chinese Medicine Hospital, Ningbo, China. Hauptthemen laut MEDLINE: Lung Neoplasms, Bronchial Neoplasms, Fasting, Tracheal Neoplasms. Die Arbeit wurde bisher 2-mal zitiert (Crossref). Der Volltext ist frei in PubMed Central verfügbar.
Abstract (Originalsprache)
Background
We aimed to evaluate the situation and change trends in the tracheal, bronchus, and lung (TBL) cancer burden attributable to high fasting plasma glucose (HFPG) stratified by gender, age, region, country, and sociodemographic index (SDI).
Methods
We evaluated the age-standardized death rate (ASDR) and disability-adjusted life years (DALYs) rate of TBL cancer attributable to HFPG and their corresponding estimated annual percentage change (EAPC) trends in 204 countries and 21 regions.
Results
Globally from 1990 to 2019, the ASDR (EAPC=0.98; 95% confidence interval [CI]: 0.82–1.15) and age-standardized DALY rate (EAPC=0.68; 95% CI: 0.55–0.82) of TBL cancer attributable to HFPG trended upward. Furthermore, the steepest increment in age-standardized death and DALY rates were noted in low-SDI regions (EAPC=1.32; EAPC=1.35) and the North Africa/Middle East region (EAPC=2.66, ESPC=2.56) among all five SDI regions and 21 global geographic regions, respectively. Among the 204 countries, the highest growth rate in the ASDR was found in Georgia (EAPC=4.33, 95% CI: 3.66–5.00), and the highest growth rate in the age-standardized DALY rate occurred in Egypt (EAPC=4.34, 95% CI: 4.22–4.47). The highest ASDR and age-standardized DALY rate occurred in people over the age of 65 years, and in the 21 geographic regions, SDIs were negatively correlated with ASDRs and EAPCs in DALYs.
Conclusion
The global burden of TBL cancer attributable to HFPG trended upward. The most significant increase in burden was observed in low-SDI regions and countries.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oncology, Ninghai Traditional Chinese Medicine Hospital, Ningbo, China.
- Department of Oncology, Ningbo Municipal Hospital of Traditional Chinese Medicine, Affiliated Hospital of Zhejiang Chinese Medical University, Ningbo, China.
ORCID-Profile: Jingyi Zhou, Chenglong Xi, Zhiyu Luan, Lufeng Mao, Shiliang Ling
Zitieren
APA
Zhou, J., Xi, C., Luan, Z., Mao, L., & Ling, S. (2025). Burden of Tracheal, Bronchus, and Lung Cancer Attributable to High Fasting Plasma Glucose. Archives of Iranian Medicine. https://doi.org/10.34172/aim.33332
Vancouver
Zhou J, Xi C, Luan Z, Mao L, Ling S. Burden of Tracheal, Bronchus, and Lung Cancer Attributable to High Fasting Plasma Glucose. Archives of Iranian Medicine. 2025. doi:10.34172/aim.33332
BibTeX
@article{Zhou2025,
author = {Zhou, Jingyi and Xi, Chenglong and Luan, Zhiyu and Mao, Lufeng and Ling, Shiliang},
title = {Burden of Tracheal, Bronchus, and Lung Cancer Attributable to High Fasting Plasma Glucose},
journal = {Archives of Iranian Medicine},
year = {2025},
doi = {10.34172/aim.33332}
}
EUVIMED